INVESTOR NEWS

Feb 11, 2021

4Q 2020 Results and preliminary annual report

Moss, 11 February 2020 Gentian Diagnostics AS announces its results for the 4th quarter and 2020 preliminary..

Jan 22, 2021

SARS-CoV-2 antibody test moving to the next development phase

Moss, 22.01.2021 Gentian Diagnostics AS is pleased to announce that its high-throughput SARS-CoV-2 antibody..

Dec 09, 2020

Financial Calendar

Financial calendar for Gentian Diagnostics AS

Nov 20, 2020

New study results confirm the value of calprotectin in management of COVID-19 patients

Moss, Norway 20.11.2020 Gentian Diagnostics AS is pleased to announce that the results from a study conducted..

Nov 05, 2020

Gentian Diagnostics divests its subsidiary PreTect AS

Gentian Diagnostics today announces the divestiture of its subsidiary PreTect AS to Mel-Mont Medical, Inc...

Oct 22, 2020

Presentation of 2020 third quarter results for Gentian Diagnostics AS

Gentian Diagnostics AS will present its 2020 third quarter results on October 29th at 10.00 am.